Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - azadirachtin(11.82g/l)+methomyl(225g/l)+chlorpyrifos(500g/l) + others - various

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 44040 - neural-tissue electrical stimulation lead - ans lamitrode s-series (s4 and s8) leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. lamitrode s-series leads are intended to be used with advanced neuromodulation system?s ipgs, receivers, transmitters, patient programmers, and extensions.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 44040 - neural-tissue electrical stimulation lead - ans lamitrode leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. lamitrode leads are intended to be used with advanced neuromodulation system's ipgs, receivers, transmitters, patient programmers, and extensions.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 44040 - neural-tissue electrical stimulation lead - ans lamitrode leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. lamitrode leads are intended to be used with advanced neuromodulation system's ipgs, receivers, transmitters, patient programmers, and extensions.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 44040 - neural-tissue electrical stimulation lead - ans lamitrode s-series (s4 and s8) leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. lamitrode s-series leads are intended to be used with advanced neuromodulation system?s ipgs, receivers, transmitters, patient programmers, and extensions.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 44040 - neural-tissue electrical stimulation lead - ans lamitrode leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. lamitrode leads are intended to be used with advanced neuromodulation system?s ipgs, receivers, transmitters, patient programmers, and extensions.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - fluazinam(500g/l)+metosulam(100g/l)+ethofumesate(500g/l) + others - various

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - cu as oxychloride(500g/kg)+tebuconazole(430g/l)+2,4-d as ipa(300g/l) + others - various

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - metosulam(100g/l)+pendimethalin+sulfometuron-methyl(750g/kg) + others - herbicide